Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ZD9393 (Zoladex) 10.8 mg|DRUG: ZD9393 (Zoladex) 3.6 mg
Sponsor: AstraZeneca